The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Stroke Prevention Trial in Sickle Cell Anemia
Open accessAbstract
Stroke occurs in 7-8% of children with Sickle Cell Disease (Hb SS) and is a major cause of morbidity. Rates of recurrence have been reduced from 46-90% to less than 10% through chronic blood transfusions. Prevention of first stroke, however, would be preferable because even one stroke can cause irreversible brain injury. Transcranial Doppler (TCD) ultrasound can detect arterial blood flow rates associated with subsequent stroke risk. By combining TCD screening and a potentially effective treatment, first stroke may be prevented. The Stroke Prevention Trial in Sickle Cell Anemia (STOP) is the first stroke prevention trial in Hb SS and the first randomized, controlled use of transfusion in Hb SS. This multi-center trial is designed to test whether reducing sickle hemoglobin to 30% or less with periodic blood transfusions will reduce first-time stroke by at least 70% compared to standard care. Primary endpoints will be clinically evident symptoms of cerebral infarction with consistent findings on Magnetic Resonance Imaging and Angiography (MRI/MRA) or symptomatic intracranial hemorrhage. Secondary endpoints will be asymptomatic brain lesions detected by MRI in brain areas not involved in primary endpoints. The design calls for a 6-month start-up interval, 18 months of TCD screening and randomization, and observation for stroke from entry through month 54. Key features of the trial are standardized TCD and MRI/MRA protocols interpreted blindly, and blinded adjudication of endpoints. The sample size (60 per treatment group) is based on prospective data relating TCD velocity to risk of stroke. A time-averaged mean velocity of > or = 200 cm/sec is associated with a 46% risk of cerebral infarction over 39 months. The sample size is sufficient to detect 70% reduction in the primary endpoint at 90% power. This trial will determine if transfusion is effective in the primary prevention of stroke. Secondary aims may further the understanding of the effects of transfusion on the brain and guide future research into cerebrovascular disease in Hb SS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries
Aaslid, R., Markwalder, T.-M., & Nornes, H. (1982) · Journal of Neurosurgery · doi:10.3171/jns.1982.57.6.0769 · Cited by 3,046
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.-L., McKie, K., Figueroa, R., Litaker, M., Thompson, W., & Hess, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260905 · Cited by 658
Self-citationThe natural history of stroke in sickle cell disease
Powars, D., Wilson, B., Imbus, C., Pegelow, C., & Allen, J. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90772-6 · Cited by 594
Self-citationStroke in a cohort of patients with homozygous sickle cell disease
Balkaran, B., Char, G., Morris, J. S., Thomas, P. W., Serjeant, B. E., & Serjeant, G. R. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80897-2 · Cited by 419
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions
Pegelow, C. H., Adams, R. J., McKie, V., Abboud, M., Berman, B., Miller, S. T., Olivieri, N., Vichinsky, E., Wang, W., & Brambilla, D. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70204-0 · Cited by 367
Self-citationLEIKIN, S. L., Gallagher, D. M., Kinney, T. R., Sloane, D., Klug, P., & RIDA, W. N. (1989) · PubMed · Cited by 361
Self-citationOcclusion of Large Cerebral Vessels in Sickle-Cell Anemia
Stockman, J. A., Nigro, M. A., Mishkin, M. M., & Oski, F. A. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210262871703 · Cited by 334
Russell, M., Goldberg, H., Hodson, A., Kim, H., Halus, J., Reivich, M., & Schwartz, E. (1984) · Blood · doi:10.1182/blood.v63.1.162.162 · Cited by 324
Mortality in Children and Adolescents With Sickle Cell Disease
Leikin, S. L., Gallagher, D., Kinney, T. R., Sloane, D., Klug, P., & Rida, W. (1989) · Pediatrics · doi:10.1542/peds.84.3.500 · Cited by 320
Self-citationWilimas, J. A., Goff, J. R., Anderson, H., Langston, J. W., & Thompson, E. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80803-1 · Cited by 156
Cited by
Lackland, D. T., Roccella, E. J., Deutsch, A. F., Fornage, M., George, M. G., Howard, G., Kissela, B. M., Kittner, S. J., Lichtman, J. H., Lisabeth, L. D., et al. (2014) · Stroke · doi:10.1161/01.str.0000437068.30550.cf · Cited by 815
Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa050460 · Cited by 635
Neurologic Outcome in Survivors of Childhood Arterial Ischemic Stroke and Sinovenous Thrombosis
deVeber, G. A., MacGregor, D., Curtis, R., & Mayank, S. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500508 · Cited by 636
The hypercoagulable state in thalassemia
Eldor, A., & Rachmilewitz, E. A. (2002) · Blood · doi:10.1182/blood.v99.1.36 · Cited by 503
The Pediatric Stroke Outcome Measure: A Validation and Reliability Study
Kitchen, L., Westmacott, R., Friefeld, S., MacGregor, D., Curtis, R., Allen, A., Yau, I., Askalan, R., Moharir, M., Domi, T., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.639583 · Cited by 271
Metadata
- Authors
- Adams, R. J., McKie, V. C., Brambilla, D., Carl, E., Gallagher, D., Nichols, F. T., Roach, S., Abboud, M., Berman, B., Driscoll, C., Files, B., Hsu, L., Hurlet, A., Miller, S., Olivieri, N., Pegelow, C., Scher, C., Vichinsky, E., Wang, W., Woods, G., Kutlar, A., Wright, E., Hagner, S., Tighe, F., Lewin, J., Cure, J., Zimmerman, R. A., & Waclawiw, M. A.
- Venue
- Controlled Clinical Trials
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 19
- Issue
- 1
- Pages
- 110-129
- ISSN
- 0197-2456 (ISSN-L)
- OpenAlex
- W1994951969
- Cited by
- 278
- References
- 18
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stroke Prevention Trial in Sickle Cell Anemia. https://app.cochat.ai/papers/10.1016/s0197-2456(97)00099-8
- The paper
- Adams, R. J., McKie, V. C., Brambilla, D., Carl, E., Gallagher, D., Nichols, F. T., Roach, S., Abboud, M., Berman, B., Driscoll, C., Files, B., Hsu, L., Hurlet, A., Miller, S., Olivieri, N., Pegelow, C., Scher, C., Vichinsky, E., Wang, W., . . . Waclawiw, M. A. (1998). Stroke Prevention Trial in Sickle Cell Anemia. Controlled Clinical Trials. https://doi.org/10.1016/s0197-2456(97)00099-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.